Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Fennec Pharmaceuticals Inc (NQ: FENC )

5.240 -0.050 (-0.95%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 240,281
Open 5.270
Bid (Size) 5.240 (73)
Ask (Size) 5.250 (2)
Prev. Close 5.290
Today's Range 5.180 - 5.280
52wk Range 5.000 - 11.92
Shares Outstanding 27,364,335
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
FENC Stock Earnings: Fennec Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024
FENC stock results show that Fennec Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
3 Dirt-Cheap Stocks Under $10 That Could EXPLODE!
These dirt cheap stocks under $10 have the potential to rise rapidly and create fortunes for bold investors. 
Via InvestorPlace

Performance

YTD
-52.88%
-52.88%
1 Month
-6.93%
-6.93%
3 Month
-18.38%
-18.38%
6 Month
-51.48%
-51.48%
1 Year
-28.51%
-28.51%

More News

Read More
Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Fennec Pharmaceuticals's Earnings Outlook
Via Benzinga
Earnings Scheduled For November 6, 2023
Via Benzinga
Preview: Fennec Pharmaceuticals's Earnings
Via Benzinga
Analyst Ratings for Fennec Pharmaceuticals
Via Benzinga
FENC Stock Earnings: Fennec Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
FENC Stock Earnings: Fennec Pharmaceuticals Misses EPS, Beats Revenue for Q4 2023
Via InvestorPlace
Earnings Scheduled For March 21, 2024
Via Benzinga
Recap: Fennec Pharmaceuticals Q1 Earnings
Via Benzinga
Earnings Outlook For Fennec Pharmaceuticals
Via Benzinga
Analyst Ratings for Fennec Pharmaceuticals
Via Benzinga
Fennec Pharmaceuticals Inc. (NASDAQ: FENC) Highlighted for Surprising Price Action
Via Investor Brand Network
Fennec Pharmaceuticals Inc. (NASDAQ: FENC) Making Surprising Moves in Monday Session
Via Investor Brand Network
7 Biotech Stocks Sitting in the Sweet Spot
Via InvestorPlace
US Stocks Open Lower; Dow Dips 250 Points
Via Benzinga
Expert Ratings for Fennec Pharmaceuticals
Via Benzinga
What 4 Analyst Ratings Have To Say About Fennec Pharmaceuticals
Via Benzinga
4 Analysts Have This to Say About Fennec Pharmaceuticals
Via Benzinga
Where Fennec Pharmaceuticals Stands With Analysts
Via Benzinga
After Two FDA Rejections, Fennec Pharma Lead Drug Scores US Approval For Chemo-Induced Hearing Loss
Via Benzinga
Why Stabilis Solutions Shares Jumped Over 71%; Here Are 70 Biggest Movers From Yesterday
Via Benzinga
Why Adamis Pharmaceuticals Is Trading Lower By Around 44%, Here Are 46 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.